Non–Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function
出版年份 2019 全文链接
标题
Non–Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function
作者
关键词
-
出版物
STROKE
Volume 50, Issue 6, Pages 1480-1489
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2019-05-14
DOI
10.1161/strokeaha.118.024264
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Antithrombotic Therapy for Atrial Fibrillation
- (2018) Gregory Y.H. Lip et al. CHEST
- Edoxaban in Asian Patients With Atrial Fibrillation
- (2018) So-Ryoung Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of Propensity Score Methods and Covariate Adjustment
- (2017) Markus C. Elze et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Changing Landscape for Stroke Prevention in AF
- (2017) Menno V. Huisman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study
- (2017) So-Ryoung Lee et al. PLoS One
- Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation
- (2017) Myung-Jin Cha et al. STROKE
- Stroke prevention in atrial fibrillation: Past, present and future
- (2017) Ben Freedman et al. THROMBOSIS AND HAEMOSTASIS
- Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 TrialClinical Perspective
- (2016) Erin A. Bohula et al. CIRCULATION
- Population Pharmacokinetics of Edoxaban in Patients with Non-Valvular Atrial Fibrillation in the ENGAGE AF-TIMI 48 Study, a Phase III Clinical Trial
- (2016) Elke H. J. Krekels et al. CLINICAL PHARMACOKINETICS
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry
- (2016) Seil Oh et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease
- (2016) Yee C. Lau et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2016) Torben Bjerregaard Larsen et al. BMJ-British Medical Journal
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2016) Torben Bjerregaard Larsen et al. BMJ-British Medical Journal
- Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time
- (2016) Ziad Hijazi et al. JAMA Cardiology
- Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
- (2015) Christian T Ruff et al. LANCET
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
- (2015) Peter C. Austin et al. STATISTICS IN MEDICINE
- Edoxaban population pharmacokinetics and exposure–response analysis in patients with non-valvular atrial fibrillation
- (2014) Ophelia Q. P. Yin et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation
- (2013) Ziad Hijazi et al. CIRCULATION
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments
- (2013) Peter C. Austin STATISTICS IN MEDICINE
- Impact of Global Geographic Region on Time in Therapeutic Range on Warfarin Anticoagulant Therapy: Data From the ROCKET AF Clinical Trial
- (2013) Daniel E. Singer et al. Journal of the American Heart Association
- Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
- (2012) Stefan H. Hohnloser et al. EUROPEAN HEART JOURNAL
- Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation
- (2012) Jeanne Mendell et al. THROMBOSIS AND HAEMOSTASIS
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
- (2009) Peter C. Austin STATISTICS IN MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now